A naukri.com initiative
Bioengineer
2w
43
Image Credit: Bioengineer
hnRNPL Drives PIK3CB Activation, Boosts Ovarian Cancer Glycolysis
- A novel study reveals how hnRNPL drives PIK3CB activation, boosting glycolysis in ovarian cancer through phase separation-mediated transcriptional activation.
- Phase separation, a fundamental organizational principle, forms hnRNPL condensates that activate PIK3CB, a key oncogene, leading to enhanced glycolytic activity in malignant ovarian cells.
- This groundbreaking research sheds light on the intricate biochemical pathways regulating cancer cell behavior and offers new therapeutic avenues for disrupting tumor metabolism.
- hnRNPL, an RNA-binding protein, undergoes phase separation to upregulate PIK3CB, initiating a cascade that enhances glycolysis and supports malignant cell growth.
- Live-cell imaging reveals the dynamic assembly of hnRNPL condensates in response to cellular cues, impacting glycolytic phenotype and tumor viability.
- Targeting hnRNPL condensates shows promise in reversing ovarian cancer cell metabolism, reducing proliferation, and increasing susceptibility to metabolic inhibitors.
- The study challenges traditional drug discovery by focusing on disrupting dynamic biomolecular assemblies rather than static protein domains, offering new therapeutic strategies for ovarian cancer.
- Interdisciplinary approaches combining cell biology, biophysics, genomics, and metabolism provide a comprehensive understanding of hnRNPL's role in ovarian tumor aggressiveness.
- hnRNPL's phase separation-mediated modulation of PIK3CB highlights a convergence point in cancer biology, suggesting broader implications for metabolic adaptation in various malignancies.
- This research sets a new standard for mechanistic studies in cancer biology and paves the way for future investigations into the clinical significance of hnRNPL phase separation in tumor progression and treatment.
Read Full Article
2 Likes
For uninterrupted reading, download the app